27467869|t|CT -guided fine-needle aspiration of abdominal and retroperitoneal small lesions with the coaxial technique using MPR images
27467869|a|To demonstrate the advantages of CT -guided fine-needle aspiration (FNA) of abdominal and retroperitoneal small lesions with the coaxial technique using MPR images. The study included retrospectively 50 patients who underwent CT -guided FNA of abdominal and/or retroperitoneal small lesion (<30 mm). Patients with suspected lymphomas or sarcomas were excluded. Cytology reports were the reference standard. The cytology was diagnostic in 48/50 biopsies (96%): out of 41 neoplastic lesions (85%), 37 were malignant (90.2%) and 4 were benign (9.8%); 7 out of 48 were non-neoplastic (14.6%). No procedural complications were observed (0%). By using MPR images there is an effective improvement in coaxial CT -guided FNA of abdominal and retroperitoneal small lesions.
27467869	0	2	CT	T060	C0040405
27467869	11	33	fine-needle aspiration	T061	C0973251
27467869	37	46	abdominal	T029	C0000726
27467869	51	66	retroperitoneal	T030	C0035359
27467869	67	72	small	T081	C0700321
27467869	73	80	lesions	T033	C0221198
27467869	90	107	coaxial technique	T059	C0022885
27467869	114	117	MPR	T060	C2107023
27467869	118	124	images	T170	C1704254
27467869	158	160	CT	T060	C0040405
27467869	169	191	fine-needle aspiration	T061	C0973251
27467869	193	196	FNA	T061	C0973251
27467869	201	210	abdominal	T029	C0000726
27467869	215	230	retroperitoneal	T030	C0035359
27467869	231	236	small	T081	C0700321
27467869	237	244	lesions	T033	C0221198
27467869	237	244	lesions	T033	C0221198
27467869	254	271	coaxial technique	T059	C0022885
27467869	278	281	MPR	T060	C2107023
27467869	282	288	images	T170	C1704254
27467869	309	324	retrospectively	T033	C3846445
27467869	328	336	patients	T101	C0030705
27467869	351	353	CT	T060	C0040405
27467869	362	365	FNA	T061	C0973251
27467869	369	378	abdominal	T029	C0000726
27467869	386	401	retroperitoneal	T030	C0035359
27467869	402	407	small	T081	C0700321
27467869	425	433	Patients	T101	C0030705
27467869	439	448	suspected	T078	C0750491
27467869	449	458	lymphomas	T191	C0024299
27467869	462	470	sarcomas	T191	C1261473
27467869	486	494	Cytology	T091	C0010819
27467869	495	502	reports	T170	C0684224
27467869	512	530	reference standard	T081	C0034925
27467869	536	544	cytology	T091	C0010819
27467869	549	559	diagnostic	T169	C0348026
27467869	569	577	biopsies	T060	C0005558
27467869	595	605	neoplastic	T080	C1709160
27467869	606	613	lesions	T033	C0221198
27467869	629	638	malignant	T191	C0006826
27467869	658	664	benign	T080	C0205183
27467869	690	704	non-neoplastic	T047	C1709246
27467869	714	716	No	T033	C1513916
27467869	717	741	procedural complications	T046	C1141861
27467869	771	774	MPR	T060	C2107023
27467869	775	781	images	T170	C1704254
27467869	794	803	effective	T080	C1704419
27467869	804	815	improvement	T077	C2986411
27467869	819	826	coaxial	T082	C1254362
27467869	827	829	CT	T060	C0040405
27467869	838	841	FNA	T061	C0973251
27467869	845	854	abdominal	T029	C0000726
27467869	859	874	retroperitoneal	T030	C0035359
27467869	875	880	small	T081	C0700321
27467869	881	888	lesions	T033	C0221198